Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Insomnia Prevention in Children With Acute Lymphoblastic Leukemia

NCT05866887 is registered in ClinicalTrials.gov with Dana-Farber Cancer Institute as lead sponsor.

NCT NCT05866887
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05866887 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Insomnia Prevention in Children With Acute Lymphoblastic Leukemia
Lead sponsor
Dana-Farber Cancer Institute
Phase
Not applicable
Overall status
Completed
Start date
September 26, 2023
Completion date
June 5, 2024
Enrollment
25 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

acute lymphoblastic leukemia, leukemia, pediatric acute lymphoblastic leukemia